Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).
about
Inhibition of IAPP Aggregation and Toxicity by Natural Products and DerivativesExploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregationIdentification of Rv3852 as an Agrimophol-Binding Protein in Mycobacterium tuberculosisInfluence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid PolypeptideMapping the structure of amyloid nucleation precursors by protein engineering kinetic analysis.Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.The Surprising Role of Amyloid Fibrils in HIV InfectionSynthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β SpeciesMutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactionsInhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption.Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β speciesProtein folding and aggregation into amyloid: the interference by natural phenolic compoundsGallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.Bioavailability of a lipidic formulation of curcumin in healthy human volunteers.IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-D-glucose.GC for flavonoids analysis: Past, current, and prospective trends.Natural product-based amyloid inhibitors.Brazilin Inhibits Prostatic Acidic Phosphatase Fibrillogenesis and Decreases its Cytotoxicity.The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism.Fluorescence detection of cationic amyloid fibrils in human semen.Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrilsEpigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.Effect of Green Tea Polyphenol Epigallocatechin-3-gallate on the Aggregation of αA(66-80) Peptide, a Major Fragment of αA-crystallin Involved in Cataract Development.A time-resolved study on the interaction of oppositely charged bicelles--implications on the charged lipid exchange kinetics.Sulfonated Compounds Bind with Prostatic Acid Phosphatase (PAP248–286) to Inhibit the Formation of Amyloid Fibrils.3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor.
P2860
Q27013875-D871F388-1F91-4692-8EC5-0D1B3D86D923Q28484823-67980CC3-7D24-4075-85A0-9B397DDBEC59Q28547278-4B9F2F5B-6156-458B-996A-41F48DCD16C6Q28818425-B288FCBF-312C-4BED-95DD-0105153DFB96Q30009502-3510FB55-F67E-4B07-9249-6E885ED40CCCQ30360888-6B237C91-D1BC-41B6-B6BE-0D6315836F91Q30427825-E71D1961-F867-4C2D-ACDE-E9A30A072613Q33570363-B123F149-5B41-466A-BE13-874DBFB895DDQ34441109-F47F3EE1-727E-459D-9A14-B951D7E26E6FQ35027146-3F2B2B4F-2D93-49FA-9573-A3DC8AC90D39Q35589369-2C12DB43-628F-4D33-9A0D-14C908DFDC8CQ36012254-BB0BF415-5F27-479A-AD9F-620FA309B5F9Q36090859-88677B99-CDB2-4CF7-9298-689DF591DB8CQ36318054-775061C3-5564-43D3-B330-7DA3E46123B7Q36528314-03BC3A96-2AB5-4EAA-8A85-679C03763F16Q36673287-CB896145-EC1C-46E0-995A-D6F1E66D7892Q37007345-07D1300A-CC14-44BD-B4E3-41212A00CE72Q37065703-7161F57A-E25D-4782-B710-C7A69329516EQ37327857-BCA6CC47-2F6D-4666-A862-517AFC97C05EQ37642975-69212458-4B15-473C-80A8-381B28A55E46Q38068815-739D8375-D435-49E6-86D0-31846A626E20Q38733078-7FBF10CE-126B-425E-8168-3B7EACEDE1B7Q40288210-8764770B-C199-45A0-9D30-D432DBB5C8F5Q40818380-9D8993D6-CF8B-4B7E-9E74-70C5FC8DC861Q41878210-F13109BB-C70D-4040-9E55-987B9E5B0ED2Q42090197-A1844813-0BD8-49D5-AE96-D98E1B708437Q42327795-24358AAA-896E-43B1-952A-28D77E62A017Q48215239-19FD45C6-3F2E-48B8-8B24-F93F87A981C5Q48752782-EEB4C5D5-47ED-45F5-A026-0AC92BC7D117Q53620109-8F3F1ACD-0AB3-45E4-B4D3-11B455E926F0Q55402163-F9381E8D-F9C7-4065-90A8-24593E593E5AQ55435176-64531F2A-1496-45AE-8240-2EF538A8FCA8
P2860
Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Site specific interaction of t ...... amyloid precursor peptide PAP
@nl
Site specific interaction of t ...... recursor peptide PAP(248-286).
@en
type
label
Site specific interaction of t ...... amyloid precursor peptide PAP
@nl
Site specific interaction of t ...... recursor peptide PAP(248-286).
@en
prefLabel
Site specific interaction of t ...... amyloid precursor peptide PAP
@nl
Site specific interaction of t ...... recursor peptide PAP(248-286).
@en
P2093
P2860
P356
P1476
Site specific interaction of t ...... recursor peptide PAP(248-286).
@en
P2093
Jeffrey R Brender
Kevin Hartman
Nataliya Popovych
Peter M Macdonald
Ronald Soong
Subramanian Vivekanandan
Venkatesha Basrur
P2860
P304
P356
10.1021/JP2121577
P407
P577
2012-03-07T00:00:00Z